BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2277605)

  • 1. Respective roles of 25 hydroxy-vitamin D, PTH, phosphate and renal function for the 1-alpha-hydroxylase activity in primary hyperparathyroidism.
    Frølich A; Nielsen BF; Transbøl I
    Miner Electrolyte Metab; 1990; 16(4):210-5. PubMed ID: 2277605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
    Moosgaard B; Vestergaard P; Heickendorff L; Mosekilde L
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):35-42. PubMed ID: 17201799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the plasma concentration of 25-hydroxyvitamin D determine the level of 1,25-dihydroxyvitamin D in primary hyperparathyroidism?
    Frølich A; Storm T; Thode J
    Miner Electrolyte Metab; 1996; 22(4):203-6. PubMed ID: 8807622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of secondary hyperparathyroidism (SHPT) and causal factors in adult population in Reykjavík area].
    Karlsson SL; Indridason OS; Franzson L; Sigurdsson G
    Laeknabladid; 2005 Feb; 91(2):161-9. PubMed ID: 16155312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of effect of 24,25-dihydroxycholecalciferol on serum immunoreactive PTH in patients with persistent hyperparathyroidism after renal transplantation.
    Friedlander MA; Horst RL; Hawker CD
    Clin Nephrol; 1984 Oct; 22(4):206-10. PubMed ID: 6391769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum osteocalcin and vitamin D in postmenopausal diabetic azotemics.
    Lu KC; Shieh SD; Chyr SH; Lin SH; Li BL; Diang LK; Chen WQ; Lin YF
    Diabetes Res; 1993; 22(3):97-104. PubMed ID: 8076446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical importance of disorders of vitamin D metabolism].
    Flury W
    Schweiz Med Wochenschr; 1978 Jan; 108(4):129-33. PubMed ID: 341302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
    Yendt ER; Kovacs KA; Jones G
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):855-63. PubMed ID: 18419790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of parathyroid hormone and vitamin D in essential hypertension.
    Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the understanding of the metabolism and functions of vitamin D.
    Ross FP; Henry HL
    Clin Orthop Relat Res; 1980 Jun; (149):249-67. PubMed ID: 6250754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting calcium metabolism in disorders of the kidney.
    Favus MJ
    Ann Clin Lab Sci; 1981; 11(4):327-32. PubMed ID: 7023346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peculiarities of vitamin D and of the calcium and phosphate homeostatic system in horses.
    Breidenbach A; Schlumbohm C; Harmeyer J
    Vet Res; 1998; 29(2):173-86. PubMed ID: 9601149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism.
    LoCascio V; Adami S; Galvanini G; Ferrari M; Cominacini L; Tartarotti D
    N Engl J Med; 1985 Oct; 313(18):1123-5. PubMed ID: 3840228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Review of the concept of vitamin D "sufficiency and insufficiency"].
    Gómez Alonso C; Naves Díaz M; Rodríguez García M; Fernández Martín JL; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():73-7. PubMed ID: 12778859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone and 25-hydroxy vitamin D3: synergistic and antagonistic effects on renal phosphate transport.
    Puschett JB; Beck WS
    Science; 1975 Oct; 190(4213):473-5. PubMed ID: 1166316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatment?
    Williams CP; Child DF; Hudson PR; Soysa LD; Davies GK; Davies MG; De Bolla AR
    J Clin Pathol; 1996 Nov; 49(11):881-8. PubMed ID: 8944605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of parathyroid extract on renal vitamin D hydroxylases in Japanese quail.
    Baksi SN; Kenny AD
    Pharmacology; 1979; 18(4):169-74. PubMed ID: 461495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism.
    Gray RW; Wilz DR; Caldas AE; Lemann J
    J Clin Endocrinol Metab; 1977 Aug; 45(2):299-306. PubMed ID: 885994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained activation of renal N-methyl-D-aspartate receptors decreases vitamin D synthesis: a possible role for glutamate on the onset of secondary HPT.
    Parisi E; Bozic M; Ibarz M; Panizo S; Valcheva P; Coll B; Fernández E; Valdivielso JM
    Am J Physiol Endocrinol Metab; 2010 Nov; 299(5):E825-31. PubMed ID: 20823451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.